NVOS (Novo Integrated Sciences) NonCurrent Deferred Liabilities: $1.39 Mil (As of May. 2024)


NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences NonCurrent Deferred Liabilities?

Novo Integrated Sciences NVOS 12 NonCurrent Deferred Liabilities is $1.39 Mil as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Novo Integrated Sciences's non-current deferred liabilities for the quarter that ended in May. 2024 was $1.39 Mil.

Novo Integrated Sciences NonCurrent Deferred Liabilities Related Terms


Novo Integrated Sciences NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences NonCurrent Deferred Liabilities Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.50 1.45 1.40

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 1.40 1.40 1.40 1.39
NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $1.39 Mil mean?
Novo Integrated Sciences (NVOS) has a NonCurrent Deferred Liabilities of $1.39 Mil as of May. 2024. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Novo Integrated Sciences and its competitors.
Is Novo Integrated Sciences' NonCurrent Deferred Liabilities too high?
Novo Integrated Sciences' current NonCurrent Deferred Liabilities is $1.39 Mil. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' NonCurrent Deferred Liabilities compare to BACK and NHLG?
Novo Integrated Sciences' NonCurrent Deferred Liabilities of $1.39 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Healthcare Providers & Services company?
A good NonCurrent Deferred Liabilities depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Novo Integrated Sciences and its competitors. Novo Integrated Sciences's current NonCurrent Deferred Liabilities is $1.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current NonCurrent Deferred Liabilities of $1.39 Mil. The current NonCurrent Deferred Liabilities is $1.39 Mil. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current NonCurrent Deferred Liabilities is $1.39 Mil as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price